IL17A and inflammatory bowel disease: Additionally, IL‐17 regulates intestinal epithelial permeability (Lee et al. 2015) and amplifies TNF and IL‐6 release (Gaffen et al. 2014), thereby positioning dysregulated IL‐17 signalling as a key contributor to IBD pathophysiology.